PMID: 42037742 Female Syrian hamster analyses of bremelanotide, a US FDA approved drug for the treatment of female hypoactive sexual desire disorder
It's also essential to determine if a patient's side effects are actually related to the medication or if they have another cause
Water, Butylene Glycol, Niacinamide, Propanediol, PEG/PPG-17/6 Copolymer, 1,2-Hexanediol, Glycerin, Boerhavia Diffusa Root Extract, Ficus Carica (Fig) Fruit Extract, Ginkgo Biloba Nut Extract, Morus Alba Fruit Extract, Punica Granatum Fruit Extract, Dimethyl Sulfone, Illicium Verum (Anise) Fruit Extract, Adenosine, Phragmites Communis Extract, Salicornia Herbacea Extract, Disodium EDTA, Scutellaria Baicalensis Root Extract, PEG-40 Hydrogenated Castor Oil, Cochineal, Hydroxyethylcellulose, Sodium Hyaluronate, Alcohol, Fragrance, Sodium Polyacrylate, DNA, Dimethicone, PEG-2M, Salmon Egg Extract, Hydrogenated Lecithin, Ethylhexylglycerin, PPG-26-Buteth-26, Sucrose Distearate, Caprylyl Glycol, Hyssopus Officinalis Extract, Marrubium Vulgare Extract, Peucedanum Ostruthium Leaf Extract, Sambucus Nigra Flower Extract, Carbomer, Palmitoyl Pentapeptide-4, Acetyl Hexapeptide-8, Citric Acid, Potassium Sorbate, Sodium Benzoate, Achillea Millefolium Extract, Alchemilla Vulgaris Extract, Malva Sylvestris (Mallow) Extract, Melissa Officinalis Leaf Extract, Mentha Piperita (Peppermint) Leaf Extract, Primula Veris Extract, Veronica Officinalis Extract
The article names people with chronic kidney disease at an eGFR below 30, a history of major bleeding, or severe GI ulcer disease as needing individualized risk-benefit assessment
doi:10.1007/s11096-023-01694-7
T-2 toxin-induced apoptosis in lymphoid organs of mice
